Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 413

1.

[A Case of Postoperative Recurrence of Rectal Cancer in Which Desensitization Therapy Was Effective against Oxaliplatin Allergy in L-OHP].

Katagiri M, Miwa K, Shimomura S, Yomoda T, Tajiri K, Nagasu S, Fujino S, Koushi K, Fujita F, Kinugasa T, Akagi Y.

Gan To Kagaku Ryoho. 2018 May;45(5):875-878. Japanese.

PMID:
30026456
2.

Lung function in the late postoperative phase and influencing factors in patients undergoing pulmonary lobectomy.

Matsumoto R, Takamori S, Yokoyama S, Hashiguchi T, Murakami D, Yoshiyama K, Nishi T, Kashihara M, Mitsuoka M, Hayashida R, Kakuma T, Akagi Y.

J Thorac Dis. 2018 May;10(5):2916-2923. doi: 10.21037/jtd.2018.05.27.

3.

Tumor Spread Through Air Spaces Identifies a Distinct Subgroup With Poor Prognosis in Surgically Resected Lung Pleomorphic Carcinoma.

Yokoyama S, Murakami T, Tao H, Onoda H, Hara A, Miyazaki R, Furukawa M, Hayashi M, Inokawa H, Okabe K, Akagi Y.

Chest. 2018 Jun 19. pii: S0012-3692(18)30923-1. doi: 10.1016/j.chest.2018.06.007. [Epub ahead of print]

PMID:
29932891
4.

Endovascular Treatment for Very Early Hepatic Artery Stenosis Following Living-Donor Liver Transplantation: Report of Two Cases.

Goto Y, Shirahama N, Sasaki S, Kawahara R, Sakai H, Ishikawa H, Hisaka T, Ogata T, Yasunaga M, Akagi Y, Tanaka H, Okuda K.

Transplant Proc. 2018 Jun;50(5):1457-1460. doi: 10.1016/j.transproceed.2018.02.074. Epub 2018 Mar 10.

PMID:
29880370
5.

An elderly case of malignant small cell glioma with hemorrhage coexistent with a calcified pilocytic astrocytoma component in the cerebellar hemisphere.

Sangatsuda Y, Hata N, Suzuki SO, Akagi Y, Hatae R, Kuga D, Yoshimoto K, Momosaki S, Iwaki T, Iihara K.

Neuropathology. 2018 May 31. doi: 10.1111/neup.12478. [Epub ahead of print]

PMID:
29851180
6.

Clues to an evolutionary mystery: the genes for T-toxin, enabler of the devastating 1970 Southern Corn Leaf Blight epidemic, are present in ancestral species, suggesting an ancient origin.

Condon BJ, Elliott CE, Gonzalez J, Yun SH, Akagi Y, Wiesner-Hanks T, Kodama M, Turgeon G.

Mol Plant Microbe Interact. 2018 May 24. doi: 10.1094/MPMI-03-18-0070-R. [Epub ahead of print]

PMID:
29792566
7.

Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.

Fujino S, Kinugasa T, Sudo T, Mizobe T, Yoshida T, Yoshida N, Ohchi T, Tajiri K, Yuge K, Nagasu S, Katagiri M, Akagi Y.

Oncol Rep. 2018 Jul;40(1):101-110. doi: 10.3892/or.2018.6407. Epub 2018 Apr 30.

PMID:
29750310
8.

Pediatric ganglioglioma with an H3 K27M mutation arising from the cervical spinal cord.

Okuda T, Hata N, Suzuki SO, Yoshimoto K, Arimura K, Amemiya T, Akagi Y, Kuga D, Oba U, Koga Y, Ohga S, Iwaki T, Iihara K.

Neuropathology. 2018 Apr 19. doi: 10.1111/neup.12471. [Epub ahead of print]

PMID:
29675936
9.

Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification.

Akagi Y, Yoshimoto K, Hata N, Kuga D, Hatae R, Amemiya T, Sangatsuda Y, Suzuki SO, Iwaki T, Mizoguchi M, Iihara K.

Brain Tumor Pathol. 2018 Apr;35(2):81-89. doi: 10.1007/s10014-018-0313-4. Epub 2018 Mar 22.

PMID:
29569163
10.

The Effectiveness of Salvage Treatments for Recurrent Lesions of Oligodendrogliomas Previously Treated with Upfront Chemotherapy.

Kuga D, Hata N, Akagi Y, Amemiya T, Sangatsuda Y, Hatae R, Yoshimoto K, Mizoguchi M, Iihara K.

World Neurosurg. 2018 Jun;114:e735-e742. doi: 10.1016/j.wneu.2018.03.069. Epub 2018 Mar 16.

PMID:
29551724
11.

Relationship Between the Horizontal Part of the Sigmoid Sinus and the Line Through the Digastric Point and Posterior Edge of the Condyle: An Anatomic and Radiologic Study.

Matsuo S, Komune N, Kurogi R, Akagi Y, Iihara K.

World Neurosurg. 2018 Jun;114:e597-e604. doi: 10.1016/j.wneu.2018.03.038. Epub 2018 Mar 14.

PMID:
29548955
12.

Complete spontaneous necrosis of hepatocellular carcinoma accompanied by portal vein tumor thrombosis: A case report.

Goto Y, Uchino Y, Sasaki S, Shirahama N, Nomura Y, Akiba J, Ishikawa H, Akagi Y, Tanaka H, Okuda K.

Int J Surg Case Rep. 2018;44:220-225. doi: 10.1016/j.ijscr.2018.02.045. Epub 2018 Mar 7.

13.

Laryngeal squamous cell papilloma is highly associated with human papillomavirus.

Orita Y, Gion Y, Tachibana T, Ikegami K, Marunaka H, Makihara S, Yamashita Y, Miki K, Makino T, Akisada N, Akagi Y, Kimura M, Yoshino T, Nishizaki K, Sato Y.

Jpn J Clin Oncol. 2018 Apr 1;48(4):350-355. doi: 10.1093/jjco/hyy009.

PMID:
29447361
14.

[Evaluation of 3D Dose Distribution and Clinical Applications Using Polymer Gel Dosimeter].

Ono K, Fujimoto S, Hayashi SI, Hioki K, Miyazawa M, Akagi Y, Hirokawa Y.

Igaku Butsuri. 2017;37(3):165-172. doi: 10.11323/jjmp.37.3_165. Japanese.

15.

Surgically treated diaphragmatic perforation after radiofrequency ablation for hepatocellular carcinoma.

Nagasu S, Okuda K, Kuromatsu R, Nomura Y, Torimura T, Akagi Y.

World J Gastrointest Surg. 2017 Dec 27;9(12):281-287. doi: 10.4240/wjgs.v9.i12.281.

16.

Surgical Anatomy of the Eustachian Tube for Endoscopic Transnasal Skull Base Surgery: A Cadaveric and Radiologic Study.

Komune N, Matsuo S, Miki K, Akagi Y, Kurogi R, Iihara K, Nakagawa T.

World Neurosurg. 2018 Apr;112:e172-e181. doi: 10.1016/j.wneu.2018.01.003. Epub 2018 Jan 8.

PMID:
29325963
17.

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.

Saeki H, Emi Y, Oki E, Tokunaga S, Kakeji Y, Akagi Y, Baba H, Baba E, Maehara Y; Kyushu Study group of Clinical Cancer (KSCC).

BMC Cancer. 2018 Jan 8;18(1):57. doi: 10.1186/s12885-017-3937-6.

18.

Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.

Miyamoto Y, Oki E, Emi Y, Tokunaga S, Shimokawa M, Ogata Y, Akagi Y, Sakamoto Y, Tanaka T, Saeki H, Maehara Y, Baba H.

Anticancer Res. 2018 Jan;38(1):491-499.

PMID:
29277814
19.

Periostin Expression in Non-Small Cell Lung Cancer: Clinical Significance.

Murakami D, Takamori S, Kawahara A, Mitsuoka M, Kashihara M, Yoshiyama K, Matsumoto R, Yokoyama S, Fujimoto K, Kawaguchi A, Izuhara K, Akagi Y.

Kurume Med J. 2018 Feb 26;64(1.2):13-20. doi: 10.2739/kurumemedj.MS640012. Epub 2017 Nov 27.

20.

Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).

Miyamoto Y, Tsuji A, Tanioka H, Maekawa S, Kawanaka H, Kitazono M, Oki E, Emi Y, Murakami H, Ogata Y, Saeki H, Shimokawa M, Natsugoe S, Akagi Y, Baba H, Maehara Y.

Int J Clin Oncol. 2018 Apr;23(2):402. doi: 10.1007/s10147-017-1212-0.

PMID:
29138948
21.

Ellagic acid glycosides with hepatoprotective activity from traditional Tibetan medicine Potentilla anserina.

Morikawa T, Imura K, Akagi Y, Muraoka O, Ninomiya K.

J Nat Med. 2018 Jan;72(1):317-325. doi: 10.1007/s11418-017-1137-y. Epub 2017 Oct 10.

PMID:
29018991
22.

Evaluation of hepatocellular carcinoma spread via the portal system by 3-dimensional mapping.

Fukutomi S, Nomura Y, Nakashima O, Yano H, Tanaka H, Akagi Y, Okuda K.

HPB (Oxford). 2017 Dec;19(12):1119-1125. doi: 10.1016/j.hpb.2017.08.011. Epub 2017 Sep 6.

PMID:
28888777
23.

Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.

Tanigawa M, Nakayama M, Taira T, Hattori S, Mihara Y, Kondo R, Kusano H, Nakamura K, Abe Y, Ishida Y, Okabe Y, Hisaka T, Okuda K, Fujino K, Ito T, Kawahara A, Naito Y, Yamaguchi R, Akiba J, Akagi Y, Yano H.

Med Mol Morphol. 2018 Mar;51(1):32-40. doi: 10.1007/s00795-017-0167-6. Epub 2017 Aug 28.

PMID:
28849340
24.

High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.

Yoshimoto K, Hatae R, Suzuki SO, Hata N, Kuga D, Akagi Y, Amemiya T, Sangatsuda Y, Mukae N, Mizoguchi M, Iwaki T, Iihara K.

Neuropathology. 2018 Feb;38(1):3-10. doi: 10.1111/neup.12408. Epub 2017 Aug 25.

PMID:
28840946
25.

Synthetic studies of (23S,25R)-1α,25-dihydroxyvitamin D3 26,23-lactone (calcitriol lactone) and its derivatives.

Akagi Y, Nagata A, Odagi M, Nagasawa K.

J Steroid Biochem Mol Biol. 2018 Mar;177:240-246. doi: 10.1016/j.jsbmb.2017.07.017. Epub 2017 Jul 27.

PMID:
28757443
26.

Effective Intraluminal Shunt in Carotid Endarterectomy for Carotid Artery Near Occlusion: Technical Report.

Kawamura Y, Maruyama D, Akagi Y, Iihara K.

World Neurosurg. 2017 Oct;106:813-818. doi: 10.1016/j.wneu.2017.07.078. Epub 2017 Jul 21.

PMID:
28739521
27.

Significance of CD47 expression in gastric cancer.

Sudo T, Takahashi Y, Sawada G, Uchi R, Mimori K, Akagi Y.

Oncol Lett. 2017 Jul;14(1):801-809. doi: 10.3892/ol.2017.6257. Epub 2017 May 26.

28.
29.

Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma.

Tajiri K, Sudou T, Fujita F, Hisaka T, Kinugasa T, Akagi Y.

Anticancer Res. 2017 Jul;37(7):3817-3823. Review.

PMID:
28668881
30.

Predictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age.

Fujiyoshi K, Yamaguchi T, Kakuta M, Takahashi A, Arai Y, Yamada M, Yamamoto G, Ohde S, Takao M, Horiguchi SI, Natsume S, Kazama S, Nishizawa Y, Nishimura Y, Akagi Y, Sakamoto H, Akagi K.

Cancer Med. 2017 Jun;6(6):1255-1263. doi: 10.1002/cam4.1088. Epub 2017 May 23.

31.

A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).

Ando K, Emi Y, Suenaga T, Hamanoue M, Maekawa S, Sakamoto Y, Kai S, Satake H, Shimose T, Shimokawa M, Saeki H, Oki E, Sakai K, Akagi Y, Baba H, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).

Int J Clin Oncol. 2017 Oct;22(5):913-920. doi: 10.1007/s10147-017-1140-z. Epub 2017 May 19.

PMID:
28526907
32.

Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era.

Yokoyama S, Mitsuoka M, Kinugasa T, Hashiguchi T, Matsumoto R, Murakami D, Nishi T, Yoshiyama K, Kashihara M, Takamori S, Akagi Y.

BMC Surg. 2017 May 10;17(1):54. doi: 10.1186/s12893-017-0252-8.

33.

Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.

Yoshimoto K, Hatae R, Sangatsuda Y, Suzuki SO, Hata N, Akagi Y, Kuga D, Hideki M, Yamashita K, Togao O, Hiwatashi A, Iwaki T, Mizoguchi M, Iihara K.

Brain Tumor Pathol. 2017 Jul;34(3):103-112. doi: 10.1007/s10014-017-0287-7. Epub 2017 Apr 26.

PMID:
28447171
34.

Injection of basic fibroblast growth factor for unilateral vocal cord paralysis.

Kanazawa T, Kurakami K, Kashima K, Konomi U, Komazawa D, Nakamura K, Matsushima K, Akagi Y, Misawa K, Nishino H, Watanabe Y.

Acta Otolaryngol. 2017 Sep;137(9):962-967. doi: 10.1080/00016489.2017.1314550. Epub 2017 Apr 22.

PMID:
28434284
35.

Intersphincteric resection for very low rectal cancer: A review of the updated literature.

Shirouzu K, Murakami N, Akagi Y.

Ann Gastroenterol Surg. 2017 Apr 25;1(1):24-32. doi: 10.1002/ags3.12003. eCollection 2017 Apr. Review.

36.

Erratum to: Influence of nonsteroidal anti-inflammatory drugs on aspirin's antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction.

Shibata K, Akagi Y, Nozawa N, Shimomura H, Aoyama T.

J Pharm Health Care Sci. 2017 Apr 4;3:10. doi: 10.1186/s40780-017-0079-6. eCollection 2017.

37.

Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.

Yamamoto G, Kikuchi M, Kobayashi S, Arai Y, Fujiyoshi K, Wakatsuki T, Kakuta M, Yamane Y, Iijima Y, Mizutani H, Nakajima Y, Sudo J, Kinoshita H, Kurimoto F, Akiyama H, Uramoto H, Sakai H, Akagi Y, Akagi K.

Int J Oncol. 2017 May;50(5):1579-1589. doi: 10.3892/ijo.2017.3935. Epub 2017 Mar 27.

38.

Evaluation of Surgical Procedures for T2 Gallbladder Cancer in Terms of Recurrence and Prognosis.

Kawahara R, Shirahama T, Arai S, Muroya D, Nomura Y, Fukutomi S, Shirahama N, Takagi K, Goto Y, Akashi M, Maruyama Y, Sakai H, Ishikawa H, Hisaka T, Yasunaga M, Horiuchi H, Okuda K, Akagi Y, Tanaka H.

Kurume Med J. 2017 Apr 13;63(1.2):15-22. doi: 10.2739/kurumemedj.MS65005. Epub 2017 Mar 22.

39.

Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.

Hashiguchi T, Miyoshi H, Nakashima K, Yokoyama S, Matsumoto R, Murakami D, Mitsuoka M, Takamori S, Akagi Y, Ohshima K.

Hum Pathol. 2017 May;63:157-164. doi: 10.1016/j.humpath.2017.02.024. Epub 2017 Mar 16.

PMID:
28322854
40.

Successful Resection of a Large Rectal Adenoma Using the Transsacral Approach.

Horio T, Oka Y, Shiratsuchi I, Saisho K, Mihara Y, Kondo R, Kinugusa T, Akiba J, Akagi Y.

Kurume Med J. 2017 May 8;63(3.4):77-80. doi: 10.2739/kurumemedj.MS00009. Epub 2017 Mar 15.

41.
42.

Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.

Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Murata K, Akagi Y, Takiguchi N, Saida Y, Nakamura K, Fukuda H, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group.

Ann Surg. 2017 Aug;266(2):201-207. doi: 10.1097/SLA.0000000000002212.

PMID:
28288057
43.

Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status.

Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K.

Onco Targets Ther. 2017 Jan 18;10:429-437. doi: 10.2147/OTT.S125587. eCollection 2017.

44.

Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.

Sudo T, Nishida R, Kawahara A, Saisho K, Mimori K, Yamada A, Mizoguchi A, Kadoya K, Matono S, Mori N, Tanaka T, Akagi Y.

Ann Surg Oncol. 2017 Nov;24(12):3763-3770. doi: 10.1245/s10434-017-5796-4. Epub 2017 Feb 3.

PMID:
28160141
45.

[A Case of Laparoscopic Resection of Peritoneal Hepatocellular Carcinoma Recurrence after Percutaneous Ethanol Injection Therapy].

Muroya D, Yasunaga M, Date Y, Fukutomi S, Shirahama N, Arai S, Nakama Y, Kawahara R, Sakai H, Ishikawa H, Hisaka T, Akiba J, Akagi Y, Tanaka H, Okuda K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1761-1763. Japanese.

PMID:
28133123
46.

Insular primary glioblastomas with IDH mutations: Clinical and biological specificities.

Hata N, Hatae R, Yoshimoto K, Murata H, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Iwaki T, Mizoguchi M, Iihara K.

Neuropathology. 2017 Jun;37(3):200-206. doi: 10.1111/neup.12362. Epub 2017 Jan 24.

PMID:
28116838
47.

Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan.

Minami K, Morita M, Emi Y, Okamoto M, Tanaka E, Nagata S, Touyama T, Ohgaki K, Tanaka T, Okumura H, Suenaga T, Tokunaga S, Oki E, Kakeji Y, Akagi Y, Baba H, Natsugoe S, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).

Int J Clin Oncol. 2017 Jun;22(3):505-510. doi: 10.1007/s10147-017-1088-z. Epub 2017 Jan 18.

PMID:
28101757
48.

Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.

Fujiyoshi K, Yamamoto G, Takenoya T, Takahashi A, Arai Y, Yamada M, Kakuta M, Yamaguchi K, Akagi Y, Nishimura Y, Sakamoto H, Akagi K.

Anticancer Res. 2017 Jan;37(1):239-247.

PMID:
28011498
49.

High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.

Fujiyoshi K, Yamamoto G, Takahashi A, Arai Y, Yamada M, Kakuta M, Yamaguchi K, Akagi Y, Nishimura Y, Sakamoto H, Akagi K.

Oncol Rep. 2017 Feb;37(2):785-792. doi: 10.3892/or.2016.5323. Epub 2016 Dec 15.

PMID:
28000889
50.

Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104).

Satake H, Iwatsuki M, Uenosono Y, Shiraishi T, Tanioka H, Saeki H, Sugimachi K, Kitagawa D, Shimokawa M, Oki E, Emi Y, Kakeji Y, Tsuji A, Akagi Y, Natsugoe S, Baba H, Maehara Y; Kyushu Study Group of Clinical Cancer.

Cancer Chemother Pharmacol. 2017 Jan;79(1):147-153. doi: 10.1007/s00280-016-3204-6. Epub 2016 Dec 10.

Supplemental Content

Support Center